Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
暂无分享,去创建一个
David K Williams | Patricia C Weber | D. Chakrabarti | M. Gelb | F. Buckner | P. Weber | D. Floyd | S. Sebti | A. Hamilton | L. Nallan | W. Windsor | David K. Williams | W. V. Van Voorhis | Kasey L. Rivas | L. Lombardo | K. Yokoyama | Laxman Nallan | Kevin D Bauer | Pravin Bendale | Kasey Rivas | Kohei Yokoyama | Carolyn P Hornéy | Prakash Rao Pendyala | David Floyd | Louis J Lombardo | Andrew Hamilton | Said Sebti | William T Windsor | Frederick S Buckner | Debopam Chakrabarti | Michael H Gelb | Wesley C Van Voorhis | Carrie Hornéy | P. R. Pendyala | Pravin M. Bendale | Kevin Bauer
[1] S. Chong,et al. Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity. , 2000, Journal of medicinal chemistry.
[2] Christian Scheurer,et al. Identification of an antimalarial synthetic trioxolane drug development candidate , 2004, Nature.
[3] E. Corey,et al. Formation of olefins via pyrolysis of sulfonate esters , 1989 .
[4] C. Bowden,et al. Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro. , 2001, Cancer research.
[5] C. Lambros,et al. Synchronization of Plasmodium falciparum erythrocytic stages in culture. , 1979, The Journal of parasitology.
[6] P. Muller,et al. Synthesis Routes Towards the Farnesyl Protein Transferase Inhibitor ZARNESTRATM , 2004 .
[7] D M Leonard,et al. Ras farnesyltransferase: a new therapeutic target. , 1997, Journal of medicinal chemistry.
[8] S. Sebti,et al. Inhibitors of protein farnesyltransferase as novel anticancer agents. , 2002, Current topics in medicinal chemistry.
[9] D. Chakrabarti,et al. Protein prenyl transferase activities of Plasmodium falciparum. , 1998, Molecular and biochemical parasitology.
[10] P. Rathod,et al. Resistance to a Protein Farnesyltransferase Inhibitor in Plasmodium falciparum* , 2005, Journal of Biological Chemistry.
[11] C. Baum,et al. Sch-66336 (sarasar) and other benzocycloheptapyridyl farnesyl protein transferase inhibitors: discovery, biology and clinical observations. , 2003, Current topics in medicinal chemistry.
[12] G. Klebe,et al. Farnesyltransferase inhibitors inhibit the growth of malaria parasites in vitro and in vivo. , 2004, Angewandte Chemie.
[13] V. Stoll,et al. Aryl tetrahydropyridine inhibitors of farnesyltransferase: bioavailable analogues with improved cellular potency. , 2003, Bioorganic & medicinal chemistry letters.
[14] D. Chakrabarti,et al. In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability. , 2004, Bioorganic & medicinal chemistry.
[15] M. Gelb,et al. Differential Prenyl Pyrophosphate Binding to Mammalian Protein Geranylgeranyltransferase-I and Protein Farnesyltransferase and Its Consequence on the Specificity of Protein Prenylation* , 1997, The Journal of Biological Chemistry.
[16] S. Sebti,et al. Farnesyltransferase Inhibitors in Cancer Therapy , 2000 .
[17] S. Croft,et al. Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. , 2004, Journal of medicinal chemistry.
[18] D. Chakrabarti,et al. Protein Farnesyltransferase and Protein Prenylation inPlasmodium falciparum * , 2002, The Journal of Biological Chemistry.
[19] W. Trager,et al. Human malaria parasites in continuous culture. , 1976, Science.
[20] Wim G J Hol,et al. Drugs to Combat Tropical Protozoan Parasites , 2002, Science.
[21] Protein prenyltransferases : Isoprenoids - Biosynthesis and role in the regulation of protein function , 1992 .
[22] A. D. Rodrigues,et al. Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potency. , 2001, Journal of medicinal chemistry.
[23] C. Der,et al. Ras Family Signaling: Therapeutic Targeting , 2002, Cancer biology & therapy.
[24] J. Tokarski,et al. Design, synthesis, and structure-activity relationships of tetrahydroquinoline-based farnesyltransferase inhibitors. , 2005, Bioorganic & medicinal chemistry letters.